Photograph of Alexis J. Gilman View LinkedIn page Download V-card

Alexis J. Gilman

Phone: +1 202.624.2570
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Alexis J. Gilman is a partner in Crowell & Moring’s Antitrust & Competition Group in the firm's Washington, D.C. office. Alexis advises and represents clients on a broad range of civil antitrust and competition matters, including merger reviews and clearances, government investigations, premerger Hart-Scott-Rodino (HSR) notifications, and antitrust litigation, with a particular focus on representing merging parties and third parties in merger investigations by the Federal Trade Commission, Department of Justice, and state attorneys general offices. He also counsels businesses and trade associations on antitrust compliance. Alexis brings significant prior government experience and expertise, having joined the firm from the Federal Trade Commission, where he was Assistant Director of the Mergers IV Division. His experience spans a wide range of industries and includes deep experience in healthcare, retail, consumer goods, food and beverage, distribution, casinos and gaming, biotechnology, and energy. Alexis was recognized by Who's Who Legal in the category Competition Future Leaders - Partners in 2019 and 2020, as a Recommended Lawyer by Legal 500 in the category Antitrust: Merger Control in 2020, and by Best Lawyers in America 2021 for Antitrust.

At Crowell, select matters include:

  • Representing a multi-state integrated health system in its proposed acquisition of a large regional referral hospital.
  • Represented Summa Health in its proposed affiliation with Beaumont Health (subsequently abandoned).
  • Represented a private equity firm and its portfolio company in obtaining clearance from the FTC of an acquisition in an area subject to a Prior Notice requirement.
  • Represented a leading global manufacturer and marketer of branded consumer foods as a third party in an FTC merger investigation.
  • Represented a marketer and seller of consumer products as a third party in an FTC merger investigation.
  • Representing a multinational Fortune 20 healthcare services company as a third party in an FTC conduct investigation.
  • Represented AT&T in its successful defense of the DOJ’s suit challenging its $108 billion acquisition of Time Warner.
  • Represented a Fortune 100 healthcare services company as a third party in an FTC merger investigation.
  • Represented a grocery retailer as a third party in an FTC supermarket merger investigation.
  • Represented an office products distributor as a third party in an FTC office supplies merger investigation.
  • Counseled a national transportation-services provider and energy industry trade association on antitrust compliance issues.

Alexis joined the firm from the Federal Trade Commission, where he led a 30-attorney division and worked on some of the agency's highest-profile matters. From 2014-2017, Alexis served as the Assistant Director of the Mergers IV Division in the Bureau of Competition of the Federal Trade Commission, where he had leading roles in and oversaw investigations and litigation in various industries, including hospitals and other healthcare providers, distribution services, retail, consumer goods, food and beverage, supermarkets, funeral homes, casinos, and online gaming. Prior to this position, Alexis served as a Deputy Assistant Director of the Mergers IV Division from 2012-2014, and a Staff Attorney in the division from 2010-2012. While at the FTC, Alexis had leading roles on several high-profile merger investigations and litigation, including:


  • FTC v. Advocate/NorthShore (preliminary injunction enjoining transaction)
  • FTC v. ProMedica/St. Luke's (injunction ordering unwinding of transaction upheld by the Sixth Circuit, cert. denied)
  • In re Cabell/St. Mary’s (complaint filed, later withdrawn after state approved merger under cooperative agreement)
  • FTC v. Phoebe Putney/Palmyra (merger consummated subject to consent order)
  • Mountain States/Wellmont Health System (merger consummated under COPA and cooperative agreement)
  • CHS/HMA (consent order requiring two hospital divestitures)
  • UHS/Ascend (consent order requiring divestiture)

Retail/Consumer Goods

  • Amazon/Whole Foods
  • Dollar Tree/Family Dollar (consent order requiring divestiture of 330 stores)
  • Albertsons/Safeway (consent order requiring divestiture of 168 supermarkets)
  • Office Depot/OfficeMax
  • Men's Wearhouse/Jos. A. Bank
  • Bass Pro/Cabela's
  • Ahold/Delhaize (consent order requiring divestiture of 81 supermarkets)

Distribution, Casinos, Gaming, and Other 

  • FTC v. Sysco/US Foods (preliminary injunction enjoining $8.2 billion transaction)
  • FTC v. Staples/Office Depot (preliminary injunction enjoining $6.3 billion transaction)
  • FTC v. DraftKings/FanDuel (complaint filed, transaction abandoned)
  • FTC v. Pinnacle/Ameristar (complaint filed, $2.8 billion merger closed subject to consent order requiring divestitures)
  • SCI/Stewart Enterprises ($1.4 billion merger consummated subject to consent order requiring divestitures in 59 markets)

Prior to joining the FTC, Alexis was an associate in the Antitrust Group of a large U.S.-based law firm, where he represented Fortune 500 companies in U.S. and foreign merger investigations and other civil antitrust matters. He represented pharmaceutical, publishing, retail, chemical, energy, and private equity clients, among others. Select matters included:

  • Pfizer in its $68 billion acquisition of Wyeth.
  • Perrigo in its $808 million acquisition of PBM Products.
  • Apollo Management in connection with its portfolio company, Hexion Specialty Chemicals' acquisition of Akzo Nobel’s Inks and Adhesives Resins business.
  • Pearson in its $950 million acquisition of Harcourt Assessment and Harcourt Education International from Reed Elsevier.
  • Pharmacia in its $60 billion acquisition by Pfizer.

Alexis is a frequent speaker at ABA, American Health Lawyers Association, and other organization events. Alexis received his J.D. with honors from The George Washington University Law School where he was a member of the George Washington International Law Review. He received his B.A. from Williams College. He is originally from Maine.


  • Williams College, B.A. (1996)
  • The George Washington University Law School, J.D. (2002)


Admitted to practice: District of Columbia, Massachusetts (inactive)

Professional Activities and Memberships

  • Member of the American Bar Association and its Antitrust, Litigation, Business, and Health Law Sections
  • Member of The American Health Lawyers Association and its Antitrust, Business Law and Governance, and In-House Counsel Practice Groups
  • Member of the Hispanic National Bar Association

View More

"Navigating Healthcare and Pharma Deals Under the Biden Administration," Healthcare M&A Seminar (May 26, 2021). Panelist: Alexis J. Gilman.
"Biden’s First 100 Days: Developments to Date and What Lies Ahead," Climate Law & Environmental Finance Update (May 7, 2021). Contacts: James G. Flood, Michael K. Atkinson, Tim Shadyac, Troy A. Barsky, Byron R. Brown, Caroline E. Brown, Robert A. Burton, Matthew Cohen, Kelly T. Currie, Jodi G. Daniel, W. Scott Douglas, Carina C. Federico, Paul Freeman, Thomas P. Gies, Alexis J. Gilman, Christine B. Hawes, Robert Holleyman, Stacie Heller, S. Starling Marshall, Shelley Su, Jeane A. Thomas, CIPP/E, Scott L. Winkelman, Tiffany Wynn, Kate Beale
Client Alert / Newsletter
"Vertical Integration in Healthcare Transactions: Mitigating Risks and Creating Firewalls," Strafford Webinar (April 28, 2021). Panelist: Alexis J. Gilman.
"Don't Roll the Dice: What You Should Know About FTC Casino and Gaming Antitrust Merger Enforcement," 2021 ABA Business Law Virtual Section Annual Meeting (April 19, 2021). Panelist: Alexis J. Gilman.
South Carolina Hospitals Abandon Merger Following COPA Reversal And FTC Opposition Global Competition Review (April 13, 2021)
Media Mentions
FTC Faces Antitrust Waterloo in Illumina Challenge The Deal Pipeline (April 9, 2021)
Media Mentions
"House Antitrust Subcommittee Examines Monopoly Power and Considers Calls for More Aggressive Enforcement," Antitrust Law Alert (April 7, 2021). Contacts: Alexis J. Gilman, Jeane A. Thomas, CIPP/E, Ryan C. Tisch, Jessica Franzetti, Richard Stella, Jessica Franzetti
Client Alert / Newsletter
"Illumina/Grail – FTC’s First Vertical Merger Challenge in Decades," Antitrust Law Alert (April 5, 2021). Contacts: Connor Ahearn, Alexis J. Gilman, Karel Bourgeois, Olivier N. Antoine, Juan A. Arteaga, Rosa M. Morales
Client Alert / Newsletter
This Tactic Helps Hospitals Ease Merger Scrutiny MedPage Today (April 1, 2021)
Media Mentions
"A Harder Pill to Swallow? International Working Group Aims to Enhance Pharmaceutical-Merger Reviews," Antitrust Law Alert (March 19, 2021). Contacts: Alexis J. Gilman, Olivier N. Antoine, Alexis Victoria DeBernardis, Kate M. Watkins
Client Alert / Newsletter

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with approximately 550 lawyers representing clients in litigation and arbitration, regulatory and policy, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity, equity and inclusion. The firm has offices in Brussels, Doha, London, Los Angeles, New York, Orange County, San Francisco, Shanghai, and Washington, D.C.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2021
Attorney advertising - prior results do not guarantee a similar outcome.